Author

E. Nuermburger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

R. Tasneen· 2 shared A. A. Bauman· 1 shared C. Dide-Agossou· 1 shared C. M. Moore· 1 shared G. T. Robertson· 1 shared J. H. Grosset· 1 shared K. Rossmassler· 1 shared M. E. Ramey· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. Tasneen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivDec 21, 2021

Combination of Mycobacterium tuberculosis RS ratio and CFU improves the ability of murine efficacy experiments to distinguish between drug treatments

C. Dide-Agossou, A. A. Bauman, M. E. Ramey…·N. D. Walter

DOI 10.1128/aac.02310-21

mousebulk RNA-seq

MicrobiologybioRxivFeb 21, 2019

Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis

V. Saini, N. C. Ammerman, Y. S. Chang…·J. H. Grosset

This study tests a new TB treatment regimen combining high-dose rifapentine and clofazimine in mouse models, finding it more effective than either drug alone in shortening treatment duration.

DOI 10.1128/aac.00388-19

mouseexperimental assay